• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶 D 部分通过 LRP1 受体被内吞,并抑制 LRP1 调节的跨膜蛋白水解。

Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis.

机构信息

IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.

出版信息

Oncogene. 2012 Jun 28;31(26):3202-12. doi: 10.1038/onc.2011.501. Epub 2011 Nov 14.

DOI:10.1038/onc.2011.501
PMID:22081071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3579766/
Abstract

The aspartic protease cathepsin-D (cath-D) is a marker of poor prognosis in breast cancer that is overexpressed and hypersecreted by human breast cancer cells. Secreted pro-cath-D binds to the extracellular domain of the β-chain of the LDL receptor-related protein-1 (LRP1) in fibroblasts. The LRP1 receptor has an 85-kDa transmembrane β-chain and a noncovalently attached 515-kDa extracellular α-chain. LRP1 acts by (1) internalizing many ligands via its α-chain, (2) activating signaling pathways by phosphorylating the LRP1β-chain tyrosine and (3) modulating gene transcription by regulated intramembrane proteolysis (RIP) of its β-chain. LRP1 RIP involves two cleavages: the first liberates the LRP1 ectodomain to give a membrane-associated form, LRP1β-CTF, and the second generates the LRP1β-intracellular domain, LRP1β-ICD, that modulates gene transcription. Here, we investigated the endocytosis of pro-cath-D by LRP1 and the effect of pro-cath-D/LRP1β interaction on LRP1β tyrosine phosphorylation and/or LRP1β RIP. Our results indicate that pro-cath-D was partially endocytosed by LRP1 in fibroblasts. However, pro-cath-D and ectopic cath-D did not stimulate phosphorylation of the LRP1β-chain tyrosine. Interestingly, ectopic cath-D and its catalytically inactive (D231N)cath-D, and pro-(D231N)cath-D all significantly inhibited LRP1 RIP by preventing LRP1β-CTF production. Thus, cath-D inhibits LRP1 RIP independently of its catalytic activity by blocking the first cleavage. As cath-D triggers fibroblast outgrowth by LRP1, we propose that cath-D modulates the growth of fibroblasts by inhibiting LRP1 RIP in the breast tumor microenvironment.

摘要

天冬氨酸蛋白酶组织蛋白酶 D(cath-D)是乳腺癌预后不良的标志物,在乳腺癌细胞中过度表达和过度分泌。分泌型 pro-cath-D 与成纤维细胞中 LDL 受体相关蛋白-1(LRP1)β 链的细胞外结构域结合。LRP1 受体具有 85kDa 的跨膜β链和非共价连接的 515kDa 细胞外α链。LRP1 通过以下方式发挥作用:(1)通过其α链内化许多配体,(2)通过磷酸化 LRP1β 链酪氨酸激活信号通路,(3)通过其β链的调节膜内蛋白水解(RIP)调节基因转录。LRP1 RIP 涉及两个裂解:第一个裂解释放 LRP1 的细胞外结构域,形成膜相关形式 LRP1β-CTF,第二个裂解生成 LRP1β-细胞内结构域,LRP1β-ICD,调节基因转录。在这里,我们研究了 pro-cath-D 通过 LRP1 的内吞作用以及 pro-cath-D/LRP1β 相互作用对 LRP1β 酪氨酸磷酸化和/或 LRP1β RIP 的影响。我们的结果表明,pro-cath-D 在成纤维细胞中部分被 LRP1 内吞。然而,pro-cath-D 和异位 cath-D 并没有刺激 LRP1β 链酪氨酸的磷酸化。有趣的是,异位 cath-D 及其催化失活(D231N)cath-D 和 pro-(D231N)cath-D 都显著抑制了 LRP1 RIP,阻止了 LRP1β-CTF 的产生。因此,cath-D 通过阻止第一次裂解,独立于其催化活性抑制 LRP1 RIP。由于 cath-D 通过 LRP1 触发成纤维细胞的生长,我们提出 cath-D 通过抑制乳腺癌肿瘤微环境中的 LRP1 RIP 来调节成纤维细胞的生长。

相似文献

1
Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis.组织蛋白酶 D 部分通过 LRP1 受体被内吞,并抑制 LRP1 调节的跨膜蛋白水解。
Oncogene. 2012 Jun 28;31(26):3202-12. doi: 10.1038/onc.2011.501. Epub 2011 Nov 14.
2
Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth.组织蛋白酶 D 前体与 LRP1 β 链胞外结构域相互作用,促进 LRP1 依赖性成纤维细胞的增殖。
J Cell Sci. 2010 Oct 1;123(Pt 19):3336-46. doi: 10.1242/jcs.070938. Epub 2010 Sep 7.
3
Catalytically inactive human cathepsin D triggers fibroblast invasive growth.催化失活的人组织蛋白酶D引发成纤维细胞侵袭性生长。
J Cell Biol. 2005 Jan 31;168(3):489-99. doi: 10.1083/jcb.200403078. Epub 2005 Jan 24.
4
A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.组织蛋白酶D释放的一种9千道尔顿的基质细胞蛋白SPARC片段在三阴性乳腺癌微环境中表现出促肿瘤活性。
Theranostics. 2021 Apr 15;11(13):6173-6192. doi: 10.7150/thno.58254. eCollection 2021.
5
Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors.组织蛋白酶D前体进入乳腺癌细胞的内吞作用大多不依赖于甘露糖-6-磷酸受体。
J Cell Sci. 1998 Sep;111 ( Pt 17):2539-49. doi: 10.1242/jcs.111.17.2539.
6
Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells.乳腺癌细胞中组织蛋白酶D原的特定甘露糖-6-磷酸受体非依赖性分选
Exp Cell Res. 1994 Nov;215(1):154-63. doi: 10.1006/excr.1994.1327.
7
Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment.组织蛋白酶 D 在乳腺癌微环境中对胱抑素 C 的蛋白水解作用。
FASEB J. 2012 Dec;26(12):5172-81. doi: 10.1096/fj.12-205229. Epub 2012 Aug 16.
8
Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?组织蛋白酶 D 的病理生理学功能:针对其催化活性还是蛋白结合活性?
Biochimie. 2010 Nov;92(11):1635-43. doi: 10.1016/j.biochi.2010.05.009. Epub 2010 May 21.
9
Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer.组织蛋白酶D特异性切割在人类乳腺癌中表达的趋化因子巨噬细胞炎性蛋白-1α、巨噬细胞炎性蛋白-1β和SLC。
Am J Pathol. 2003 Apr;162(4):1183-90. doi: 10.1016/s0002-9440(10)63914-4.
10
Low density lipoprotein receptor-related protein-1 (LRP1) regulates thrombospondin-2 (TSP2) enhancement of Notch3 signaling.低密度脂蛋白受体相关蛋白-1(LRP1)调节血小板反应蛋白-2(TSP2)对 Notch3 信号的增强作用。
J Biol Chem. 2010 Jul 23;285(30):23047-55. doi: 10.1074/jbc.M110.144634. Epub 2010 May 14.

引用本文的文献

1
Cathepsins: Emerging targets in the tumor ecosystem to overcome cancers.组织蛋白酶:肿瘤生态系统中克服癌症的新兴靶点。
Semin Cancer Biol. 2025 Jul;112:150-166. doi: 10.1016/j.semcancer.2025.04.001. Epub 2025 Apr 12.
2
Cathepsins in cellular entry of human pathogenic viruses.组织蛋白酶在人类致病病毒的细胞进入过程中的作用
J Virol. 2025 Apr 15;99(4):e0164224. doi: 10.1128/jvi.01642-24. Epub 2025 Mar 26.
3
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer.一种新型 Fc 工程化的组织蛋白酶 D 靶向抗体增强 ADCC,触发肿瘤浸润 NK 细胞募集,并改善紫杉醇和恩扎卢胺联合治疗三阴性乳腺癌的效果。
J Immunother Cancer. 2024 Jan 30;12(1):e007135. doi: 10.1136/jitc-2023-007135.
4
Lysosomal peptidases-intriguing roles in cancer progression and neurodegeneration.溶酶体肽酶——在癌症进展和神经退行性变中的有趣作用。
FEBS Open Bio. 2022 Apr;12(4):708-738. doi: 10.1002/2211-5463.13372. Epub 2022 Feb 3.
5
The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis.低密度脂蛋白受体相关蛋白1在动脉粥样硬化中的双重作用
Front Cardiovasc Med. 2021 May 28;8:682389. doi: 10.3389/fcvm.2021.682389. eCollection 2021.
6
Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.溶酶体功能障碍作为神经退行性疾病的病因:来自额颞叶痴呆和肌萎缩侧索硬化症的教训。
Neurobiol Dis. 2021 Jul;154:105360. doi: 10.1016/j.nbd.2021.105360. Epub 2021 Mar 31.
7
Neuronal megalin mediates synaptic plasticity-a novel mechanism underlying intellectual disabilities in megalin gene pathologies.神经元巨蛋白介导突触可塑性——巨蛋白基因病变中智力障碍的一种新机制。
Brain Commun. 2020 Aug 25;2(2):fcaa135. doi: 10.1093/braincomms/fcaa135. eCollection 2020.
8
Contribution of the Low-Density Lipoprotein Receptor Family to Breast Cancer Progression.低密度脂蛋白受体家族对乳腺癌进展的作用
Front Oncol. 2020 Jul 30;10:882. doi: 10.3389/fonc.2020.00882. eCollection 2020.
9
: Physiological Function and Role in Disease Management.生理功能及其在疾病管理中的作用。
Cells. 2020 Jul 13;9(7):1679. doi: 10.3390/cells9071679.
10
Biomarkers of tumor invasiveness in proteomics (Review).蛋白质组学中肿瘤侵袭性的生物标志物(综述)。
Int J Oncol. 2020 Aug;57(2):409-432. doi: 10.3892/ijo.2020.5075. Epub 2020 May 28.

本文引用的文献

1
Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.细胞胆固醇调节依赖于金属蛋白酶的低密度脂蛋白受体相关蛋白-1(LRP-1)的脱落及其清除功能。
FASEB J. 2011 Aug;25(8):2770-81. doi: 10.1096/fj.10-169508. Epub 2011 Apr 25.
2
Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth.组织蛋白酶 D 前体与 LRP1 β 链胞外结构域相互作用,促进 LRP1 依赖性成纤维细胞的增殖。
J Cell Sci. 2010 Oct 1;123(Pt 19):3336-46. doi: 10.1242/jcs.070938. Epub 2010 Sep 7.
3
Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation.金属蛋白酶依赖性的低密度脂蛋白受体相关蛋白-1胞外域脱落会降低月经期间子宫内膜基质金属蛋白酶-2和-9的内吞清除率。
Endocrinology. 2009 Aug;150(8):3792-9. doi: 10.1210/en.2009-0015. Epub 2009 Apr 30.
4
LRP1 shedding in human brain: roles of ADAM10 and ADAM17.LRP1 在人脑中的脱落:ADAM10 和 ADAM17 的作用。
Mol Neurodegener. 2009 Apr 16;4:17. doi: 10.1186/1750-1326-4-17.
5
Presenilin: RIP and beyond.早老素:细胞程序性死亡及其他。
Semin Cell Dev Biol. 2009 Apr;20(2):201-10. doi: 10.1016/j.semcdb.2008.11.014. Epub 2008 Nov 27.
6
Gamma-secretase limits the inflammatory response through the processing of LRP1.γ-分泌酶通过对低密度脂蛋白受体相关蛋白1(LRP1)的加工处理来限制炎症反应。
Sci Signal. 2008 Nov 25;1(47):ra15. doi: 10.1126/scisignal.1164263.
7
Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis.凝血酶上调组织蛋白酶D,后者可促进血管生成、生长和转移。
Cancer Res. 2008 Jun 15;68(12):4666-73. doi: 10.1158/0008-5472.CAN-07-6276.
8
Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death.低密度脂蛋白受体相关蛋白的膜内蛋白水解调控介导缺血性细胞死亡。
Am J Pathol. 2008 May;172(5):1355-62. doi: 10.2353/ajpath.2008.070975. Epub 2008 Apr 10.
9
The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells.组织蛋白酶D的前肽会增加乳腺癌细胞的增殖、侵袭和转移。
Int J Oncol. 2008 Feb;32(2):491-8.
10
The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development.低密度脂蛋白受体相关蛋白调节癌细胞的存活和转移发展。
Cancer Res. 2007 Oct 15;67(20):9817-24. doi: 10.1158/0008-5472.CAN-07-0683.